Fundraising launches in DACH Cinven grabs SLV-Group ... - Unquote

uyouts
unquote
distribution. The capital will be used for further internationalisation of the business. SLV will leverage
from Cinven’s expertise in the consumer and industrial sector in Europe.
Previous funding
Hg Capital acquired SLV for €320m in 2007. Since then, the company has expanded its core business
in Übach-Palenberg and also strengthened the international distribution network.
Debt
No details regarding the debt structure were disclosed.
Company
SLV is based in Übach-Palenberg and was founded in 1979. The company is a provider of interior and
exterior lighting solutions. It operates subsidiaries in Germany, France, Italy, Belgium, Switzerland,
Hong Kong, the US and Russia.
SLV only operates as a wholesaler – its products are distributed via a network of partners supplying
about 60 countries. The business employs 190 people.
People
Justin von Simons is managing director at HgCapital Germany and Bruno Schick represented Cinven.
Advisers
Equity – Altium Capital (Corporate finance); Hengeler Mueller, Dr Emanuel Strehle, Dr Christof
Jäckle, Dr Matthias Scheifele, Dr Alf-Henrik Bischke, Dr Christian Hoefs, Dr Iris Paetzke, Dr Alexander
Ego, Maximilian Brosinger, Dr Philipp Scheuermann, Jan-Henning Wyen, Tobias A Schäfers, Eckbert
Müller, Dr Gunther Wagner (Legal).
Vendor – Macquarie (Corporate finance); Clifford Chance, Burc Hesse, Marc Besen, Dr Uwe
Schimmelschmidt, Torsten Syrbe, Thomas Weitkamp, Frederik Mühl, Dr Leif Schrader, Dr Michael
Lamsa, Cord von Mandelsloh, Susanne Baier, Carina Soesanto, Julia Wahls, Michael Samol (Legal).
Company – Willkie Farr & Gallagher, Mario Schmidt, Dr Patrick Meiisel, Dr. Christian Rolf, Jochen
Riechwald, Dr Maximilian Schwab, Sabine Weber (Legal).
Debt – Clifford Chance, Dr Bettina Steinhauer (Legal).
SECONDARY BUYOUT
CABB
n/d (>€340m)
Location Sulzbach
Sector Specialty
Chemicals
Staff 750
Turnover €311m
EBITDA €50m
Bridgepoint acquires CABB from AXA
Transaction
Private equity firm Bridgepoint has acquired German chemical specialist CABB from AXA Private
Equity in a secondary buyout for an undisclosed amount thought to be over €340m.
The transaction emerged through an auction process run by Rothschild.
Bridgepoint was attracted by the company’s good performance, which continued during the downturn,
and consistently strong revenues as well as its margin growth over the year. The investor believes the
company has potential to increase its global reach, and is planning to further grow the firm through
bolt-on acquisitions and expansion to Asia and North America.
Previous funding
AXA Private Equity acquired CABB in 2006 from Gilde Investment Funds for between €25 and 50m.
Debt was provided by DZ Bank. During the holding period CABB acquired SF Chem with backing
18 UNQUOTE APRIL 11 ENTIRE CONTENTS COPYRIGHT 2011 INCISIVE MEDIA INVESTMENTS LTD
www.unquote.com/dach